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ABSTRACT 
The aim of this review article is emphasizing on development and validation protocol which will used to develop and validate accurate, simple, 
selective and specific spectrophotometric methods for the determination of Sofosbuvir (SOF) and Ledipasvir (LDV) in pure and in their dosage 
forms. Thus it is necessary to develop methods for analysis with the help of number of analytical techniques which are available for the 
estimation of the drugs in combination. The analyst were determine the Specific, accurate, simple, selective and stability-indicating RP-HPLC 
method is developed and validated for simultaneous determination of sofosbuvir and ledipasvir in tablet dosage form.  
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Sofosbuvir Fig.1.(propan-2-yl (2S)-2-{[(S)-{[(3R,4R,5R) -5-
(2,4-dioxo-1,2,3,4-tetrahydro pyrimidin-1-yl)-4-fluoro-3-
hydroxy-4-methyloxolan-2-
yl]methoxyphenoxy)phosphoryl]amino} propanoate) is a 
prodrug nucleotide analog used as part of combination 
therapy to treat hepatitis C virus (HCV) infection or to treat 
co-infection of HIV and HCV. It has a molecular formula of 
C22H29FN3O9P and a molecular weight of 529.45.After 
metabolism to the active antiviral agent 2'-deoxy-2'-α-fluoro-
β-C-methyluridine-5'-triphosphate (also known as GS-
461203), the triphosphate serves as a defective substrate for 
the NS5B protein, an RNA dependent RNA polymerase 
required for replication of viral RNA.1 
 
Figure 1: chemical structure of Sofosbuvir 
Ledipasvir Fig.2. ((2S)-1-[(6S)-6-[5-( 9,9-difluoro -7-{2-[(1R, 
3S, 4S)-2-[(2S)-2-{[hydroxyl (methoxy) methylidene ] 
amino}-3-methyl butanoyl]-2-azabicyclo [2.2.1] heptan-3-yl] 
-1H-1,3  benzodiazol- 6-yl}-9H-fluoren-2-yl) -1H-imidazol-2-
yl]-5-azaspiro[2.4] heptan-5-yl]-2-{[hydroxyl (methoxy) 
methylidene] amino}-3-methyl butan-1-one) is a Hepatitis C 
Virus NS5A Inhibitor with potential activity against HCV. In 
combination with sofosbuvir for treatment in chronic 
hepatitis C genotype 1 patients. Upon oral administration 
and after intracellular uptake, ledipasvir binds to and blocks 
the activity of the NS5A protein. This results in the 
disruption of the viral RNA replication complex, blockage of 
HCV RNA production, and inhibition of viral replication. 
NS5A, a zinc-binding and proline rich hydrophilic 
phosphoprotein, plays a crucial role in HCV RNA replication. 2 
 
Figure 2: chemical structure of Ledipasvir 
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Validation of an analytical method is the process by which it 
is established, by laboratory studies, that the performance 
characteristics of the method meet the requirements for the 
intended analytical applications. There are two important 
reasons for validating assays in the pharmaceutical industry. 
The first, and by for the most important, is that assay 
validation is an integral part of the quality control system. 
The second is that current good manufacturing practice 
regulation requires assay validation.  
Globally, 130-150 millions of people have chronic hepatitis C 
infection. A significant number of those who are chronically 
infected will develop liver cirrhosis or liver cancer. Gilead 
Sciences overcome most common related liver diseases by its 
Great invention (Harvoni). Harvoni (90 mg ledipasvir/400 
mg sofosbuvir) approved by United States FDA. It is 
indicated for the treatment of chronic HCV genotypes 1, 4, 5, 
and 6 in adults and also indicated for the treatment of 
chronic HCV in patients co-infected with HIV 3 
The ability to provide timely, accurate, and reliable data is 
central to the discovery, development, and manufacture of 
pharmaceuticals. Analytical data are used to screen potential 
drug candidates, aid in the development of drug synthesis, 
support formulation studies, monitor the stability of bulk 
pharmaceuticals and formulated products, and test final 
products for release. The quality of analytical data is a key 
factor in the success of a drug development program. 
 
Table 1: Various Instrumental Methods of Analysis  
Instrumental Method Property Measured Application 
UV- Visible 
Spectrophotometry 
Absorption of radiation  Identification of the functional group and quantitation of 
unsaturated compounds.  
FTIR Spectroscopy Absorption of radiation  Quantitative analysis of organic compound at high conc. Level.  
Atomic Absorption 
Spectroscopy 
Absorption of radiation Quantitation of metals or metalloids 
Flame Photometry Emission of radiation Quantitation of alkali metals or alkaline earth metals.  
X-Ray Diffraction Diffraction of radiation Identification of crystal lattice structure, determination of 
percent of crystallinity in polymers. 
NMR, LC-NMR Nuclear spin energy level of a mol 
in an applied magnetic field. 
Identifies type of hydrogen and carbon in organic molecules. 
Analysis of trace impurity and degradants. 
Thermal analysis 
 ( DTA \ DSC ) 
Difference in Temperature \ heat 
energy 
Determination of melting point, Polymorphism, Drug – 
excipients compatibility  
Mass spectrometry LC-
MS \ GC-Ms 
 
Mass to charge ratio (m\e)  
 
Mol. Wt. determination Quantification of the analyte in liquid or 
gas sample. Analysis of the biological sample. Analysis of trace 
impurity and degradants.  
 
2. HIGH PERFORMANCE LIQUID 
CHROMATOGRAPHY (HPLC) 
High Performance Liquid Chromatography is the most 
widely used analytical separation technique. HPLC has been 
rapidly developed with the introduction of new pumping 
methods, more reliable columns and a variety of detectors. 
Most of the drugs in multicomponent dosage forms can be 
analyzed by HPLC methods because of the several 
advantages like rapidity, specificity, accuracy, precision and 
ease of automation in this method. HPLC method eliminates 
tedious extraction and isolation procedures. 
In HPLC, the analyst has a wide choice of chromatographic 
separation methodologies from normal to reverse phase and 
a whole range of mobile phases using isocratic (or) gradient 
elution techniques. 4 
2.1 Reverse Phase Chromatography: 
Reversed phase mode is the most popular mode for 
analytical and preparative separation of compounds of 
interest in chemical, biological, pharmaceutical, food and 
biomedical sciences. In this mode, the stationary phase is 
nonpolar hydrophobic packing with octyl or octa decyl 
functional group bonded to silica gel and the mobile phase is 
polar solvent. An aqueous mobile phase allows the use of 
secondary solute chemical equilibrium (such as ionization 
control, ion suppression, ion pairing and complexation) to 
control retention and selectivity. The polar compounds get 
eluted first in this mode and nonpolar compounds are 
retained for longer time. As most of the drugs and 
pharmaceuticals are polar in nature, they are not retained for 
longer time and hence elute faster. The different columns 
used are octa decyl silane (ODS) or C-18, C-8, C-4, etc., in the 
order of increasing polarity of the stationary phase  
2.2 Partition Chromatography: 
It is the most widely used liquid chromatographic procedure 
to separate most kinds of organic molecules. Here the 
components present in the analyte mixture distribute 
themselves between the mobile phase and stationary phase 
as the mobile phase moves through the column. The 
stationary phase actually consists of a thin liquid film either 
adsorbed or chemically bonded to the surface of finely 
divided solid particles. 5 
3. METHOD DEVELOPMENT PROTOCOL 
3.1 Selection of Chromatographic Mode  
Proper selection of the method depends upon the nature of 
the sample (ionic/ ionizable/ neutral molecule), its 
molecular weight and solubility. The drugs selected in 
present study are neutral in nature. Both the drugs are freely 
soluble in organic solvents. Hence, reversed phase HPLC was 
selected for the initial separations because of its simplicity 
and suitability.  
3.2 Selection of Stationary Phase  
On the basis of reversed phase HPLC mode and number of 
carbon present in the molecule (analyte) RP-Purosnosphere 
C18 (Grace) column (5μm, 4.6 mm × 250 mm), of following 
configuration was selected for further study.  
3.3 Selection of Mobile Phase  
Ledipasvir and Sofosbuvir are soluble in HPLC grade water 
and methanol on ultrasonication, insoluble in hexane and are 
freely soluble in methanol and water, DMSO. 6 
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3.4 Selection of Detector and Detection Wavelength  
UV-Visible detector was selected, as it is reliable and easy to 
set at the correct wavelength. 
3.5 Standard Sample Preparation Ledipasvir and 
Sofosbuvir 
An accurately weighed quantity of Ledipasvir 10 mg and 40 
mg Sofosbuvir was taken in 25 ml volumetric flask and 
dissolved in 10 ml Methanol, with the help of ultrasonication 
for about 10 min. Then the volume was made up to the mark 
using methanol to get standard stock solution.  
3.6 Optimization of HPLC Parameters  
Optimizations of HPLC process is to find a set of conditions 
that adequately separate and enable the quantification of the 
analytes from the endogenous material with acceptable 
accuracy, precision, cost, ease and speed.  
3.7 Optimization of Mobile Phase Strength  
Initially methanol and water in different ratios were tried, 
and then methanol and water at different pH will try. 7 
3.8 Optimization of Detection Wavelength  
On the basis of overlay spectra different wavelengths were 
selected. A fixed concentration of analyte mixture was 
analyzed at selected wavelengths.  
4. METHOD VALIDATION PROTOCOL 
The method was validated, in accordance with ICH guidelines 
(ICH Q2R1), for system suitability, linearity, accuracy, 
precision, repeatability, ruggedness, robustness, LOD and 
LOQ. 8 
4.1 Linearity:  
The linearity range of Ledipasvir and Sofosbuvir was 
evaluated by varying concentrations of standard solutions 
were injected into HPLC system. The linear range of 
detectability that obeys Beer’s law is dependent on the 
compound analyzed and the detector used. The working 
sample concentration and samples tested for accuracy 
should be in the linear range. The claim that the method is 
linear is to be justified with additional mention of zero 
intercept by processing data by linear least square 
regression. Data is processed by linear least square 
regression declaring the regression co-efficient and b of the 
linear equation y= ax + b together with the correlation 
coefficient of determination r2. For the method to be linear, 
the r2 value should be close to1 
4.2 Precision: 
Precision is a measure of the degree of reproducibility or of 
the repeatability of the analytical method under normal 
operating circumstances. Repeatability involves analysis of 
replicates by the analyst using the same equipment, method 
and conducting the precision study over short period of time 
while reproducibility involves precision study at different 
Occasions. 9 
 Different Laboratories  
 Different Batch of Reagent  
 Different Analysts  
 Different Equipments  
4.3 Repeatability: 
 It is normally expected that at least six replicates should be 
carried out and a table showing each individual result 
provided from which the mean, standard deviation and co-
efficient of variation should be calculated for set of n value. 
The RSD values are important for showing degree of 
variation expected when the analytical procedure is repeated 
several time in a standard situation. It should be below 2% 
for bulk drugs and below 2% for assay in finished product. 10 
4.4 Limit of Detection:  
The determination of the limit of detection of instrumental 
procedures is carried out by determining the signal-to-noise 
ratio by comparing test results from the samples with known 
concentration of analyte with those of blank samples and 
establishing the minimum level at which the analyte can be 
reliably detected. A signal-to-noise ratio of 2:1 or 3:1 is 
generally accepted. The signal-to-noise ratio is determined 
by dividing the base peak by the standard deviation of all 
data points below a set threshold. Limit of detection is 
calculated by taking the concentration of the peak of interest 
divided by three times the signal-to-noise ratio.  
For spectroscopic techniques or other methods that rely 
upon a calibration curve for quantitative measurements, the 
IUPAC approach employs the standard deviation of the 
intercept (Sa) which may be related to LOD and the slope of 
the calibration curve, b, by: LOD = 3.3 Sa / b. 11 
4.5 Limit of Quantitation  
Where the final assessment is based on an instrumental 
reading, the magnitude of background response by analyzing 
a number of blank samples and calculating the standard 
deviation of this response. The standard deviation multiplied 
by a factor (usually 10) provides an estimate of the limit of 
quantitation. In many cases, the LOQ is approximately twice 
the limit of detection. SD is the standard deviation of the 
intercept which may be related to LOQ and the slope of the 
calibration curve, b, by: 
LOQ = 10 SD / slope 
4.6 Selectivity and Specificity 
Selectivity may be expressed in terms of the bias of the assay 
results obtained when the procedure is applied to the 
analyte in the presence of expected levels of other 
components, compared to the results obtained on the same 
analyte without a added substances. 12 
4.7 Determination of Reproducibility: 
 Reproducibility means the precision of the procedure when 
it is carried out under different conditions, usually in 
different laboratories on separate, putatively identical 
samples taken from the same homogeneous batch of 
material. Comparisons of results obtained by different 
analysts, by the use of different equipments or by carrying 
out the analysis at different times can also provide valuable 
information. 13 
4.8 Ruggedness: 
The testing of ruggedness is normally suggested when the 
method is to be used in more than one laboratory. 
Ruggedness is normally expressed as the lack of the 
influence on the test results of operational and 
environmental variables of the analytical method. 
4.9 System Suitability: 
These parameters are measured during the analysis. Similar 
to the analytical method development, the system suitability 
test strategy should be revised as the analysts develop more 
experience with the assay. 14 
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5. CONCLUSION 
The presented article will give information about protocol 
considered during method development and validation. The 
method should be precise, sensitive and accurate. This 
method has simple sample preparation. The good recoveries 
and low coefficient of variation confirmed the suitability of 
proposed method for the routine analysis of LPS and SOFO in 
pharmaceuticals. 
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